Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Frontage Holdings Corp. ( (HK:1521) ) is now available.
Frontage Holdings Corporation has announced an extraordinary general meeting scheduled for January 7, 2026, to discuss and approve a share transfer agreement involving its subsidiary, Frontage Laboratories (Shanghai) Co., Ltd., and other parties. This move is expected to impact the company’s operational dynamics and could potentially enhance its market positioning by streamlining its corporate structure.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
More about Frontage Holdings Corp.
Frontage Holdings Corporation is a company incorporated in the Cayman Islands with limited liability. It operates in the pharmaceutical and biotechnology industry, focusing on providing research and development services to pharmaceutical companies.
Average Trading Volume: 381,669
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.08B
See more data about 1521 stock on TipRanks’ Stock Analysis page.